Chugai Pharmaceutical Revenue

Chugai Pharmaceutical had revenue of 315.68B JPY in the quarter ending September 30, 2024, with 22.40% growth. This brings the company's revenue in the last twelve months to 1.14T, down -10.48% year-over-year. In the year 2023, Chugai Pharmaceutical had annual revenue of 1.11T, down -11.79%.

Revenue (ttm)

1,142.35B JPY

Revenue Growth

-10.48%

P/S Ratio

n/a

Revenue / Employee

150.23M JPY

Employees

7,604

Market Cap

69.27B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,111.37B	-148.58B	-11.79%
Dec 31, 2022	1,259.95B	260.19B	26.02%
Dec 31, 2021	999.76B	212.81B	27.04%
Dec 31, 2020	786.95B	100.76B	14.68%
Dec 31, 2019	686.18B	106.40B	18.35%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.79B
SS Innovations International	16.04M
Veradigm	1.53B
Elite Pharmaceuticals	71.17M
Glass House Brands	188.29M
Northwest Biotherapeutics	1.60M
Silence Therapeutics	21.77M
BioStem Technologies	210.49M

Revenue Rankings

Chugai Pharmaceutical News

3 months ago - Chugai Pharmaceutical Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
3 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript - Seeking Alpha
5 months ago - Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market - Benzinga
6 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript - Seeking Alpha
9 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript - Seeking Alpha

More News